ahlam1399
03-12-2016, 03:54 AM
Startup Stemcentrx exploring strategic options, including sale-WSJ
March 11 (Reuters) - Stemcentrx Inc, a San Fransisco-based biotech**logy startup, is pursuing strategic alternatives including a sale, the Wall Street Journal reported.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e3465ce/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=RgHawYfuR04:UxrkPRB3_Mw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=RgHawYfuR04:UxrkPRB3_Mw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=RgHawYfuR04:UxrkPRB3_Mw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=RgHawYfuR04:UxrkPRB3_Mw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=RgHawYfuR04:UxrkPRB3_Mw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/RgHawYfuR04
March 11 (Reuters) - Stemcentrx Inc, a San Fransisco-based biotech**logy startup, is pursuing strategic alternatives including a sale, the Wall Street Journal reported.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e3465ce/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=RgHawYfuR04:UxrkPRB3_Mw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=RgHawYfuR04:UxrkPRB3_Mw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=RgHawYfuR04:UxrkPRB3_Mw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=RgHawYfuR04:UxrkPRB3_Mw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=RgHawYfuR04:UxrkPRB3_Mw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/RgHawYfuR04